Since significantly lower CD32b expression on total, naive and IgMhi MZ-like B cells and non-significantly lower expression on IgMlo MZ-like B cells from females with CIS or MS was detected, CD32b expression on these, and other B cell subsets was examined for associations with serum factors that may be related to B cell dysfunction. This evidence concerns the gene FCGR2B and in situ carcinoma.